Related references
Note: Only part of the references are listed.CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis
Ross Brown et al.
BLOOD (2012)
Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy
Jia Li et al.
BLOOD (2010)
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma
Ross D. Brown et al.
LEUKEMIA & LYMPHOMA (2009)
Regulatory T cells and multiple myeloma
Douglas E. Joshua et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells
Joel LeMaoult et al.
BLOOD (2007)
Either interleukin-12 or interferon-γ can correct the dendritic cell defect induced by transforming growth factor β1 in patients with myeloma
R Brown et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10
RD Brown et al.
BLOOD (2001)
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8+CD57+CD28- compartment
DMY Sze et al.
BLOOD (2001)
T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells
M Raitakari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
